B-
BiotechTV - News
At its R&D Day in London today, Gubra provided updates on obesity assets licensed to AbbVie and Boehringer Ingelheim, as well as highlighted its lead internal program UCN2
0:00-22:51
CEO Markus Rohrwild and CDMO Thomas Langenickel provide an update on the company's peptide based drug development side, as well as venture and CRO arms.
Publisher
BiotechTV - News
Link
podcasters.spotify.com/pod/show/biotechtv4/episodes/At-its-RD-Day-in-London-today--Gubra-provided-updates-on-obesity-assets-licensed-to-AbbVie-and-Boehringer-Ingelheim--as-well-as-highlighted-its-lead-internal-program-UCN2-e3r66t1
Published
October 27, 2026
Duration
23 min
Format
Podcast
Category
Issues ยท Science
Source
RSS feed
Host
BiotechTV
B-
BiotechTV - News
@biotechtvnews
#gubraprovidedupdates #obesityassetslicensed #leadinternalprogram #lifesciences
